Synergistic Combinatorial Stroke Therapy: A Quantal Bioassay of a GABA Agonist and a Glutamate Antagonist
- 30 June 2000
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 163 (2) , 477-489
- https://doi.org/10.1006/exnr.2000.7394
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Combination Therapy with MK-801 and α-Phenyl-tert-butyl-nitrone Enhances Protection against Ischemic Neuronal Damage in Organotypic Hippocampal Slice CulturesExperimental Neurology, 1996
- Combination therapy with U74006F (tirilazad mesylate), MK-801, insulin and diazepam in transient forebrain ischaemiaNeurological Research, 1995
- Pharmacological types of calcium channels and their modulation by baclofen in cerebellar granulesJournal of Neuroscience, 1995
- Safety, Tolerability, and Pharmacokinetics of the N -Methyl- d -Aspartate Antagonist Dextrorphan in Patients With Acute StrokeStroke, 1995
- Monoclonal Antibody to the ICAM-1 Adhesion Site Reduces Neurological Damage in a Rabbit Cerebral Embolism Stroke ModelExperimental Neurology, 1993
- Mild hypothermic intervention after graded ischemic stress in rats.Stroke, 1991
- Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemiaJournal of Neuroscience, 1990
- Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injuryNeuroscience Letters, 1989
- The Neuroprotective Action of Ketamine and MK-801 after Transient Cerebral Ischemia in RatsAnesthesiology, 1988
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986